Bcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition

V Rincheval, F Renaud, C Lemaire, N Godefroy… - Biochemical and …, 2002 - Elsevier
V Rincheval, F Renaud, C Lemaire, N Godefroy, P Trotot, V Boulo, B Mignotte, JL Vayssière
Biochemical and Biophysical Research Communications, 2002Elsevier
With the aim to identify events involved in the determination of p53-dependent apoptosis
versus growth arrest, we used rat embryo fibroblasts expressing a temperature-sensitive
mutant (tsA58) of the SV40 large tumour antigen (LT). Heat-inactivation of LT leads to p53
activation and commitment to a senescent-like state (REtsA15 cell line) or apoptosis
(REtsAF cell line). We report that senescence is associated with high levels of the anti-
apoptotic Bcl-2 protein and a cell cycle arrest in G1 phase, whereas apoptosis is associated …
With the aim to identify events involved in the determination of p53-dependent apoptosis versus growth arrest, we used rat embryo fibroblasts expressing a temperature-sensitive mutant (tsA58) of the SV40 large tumour antigen (LT). Heat-inactivation of LT leads to p53 activation and commitment to a senescent-like state (REtsA15 cell line) or apoptosis (REtsAF cell line). We report that senescence is associated with high levels of the anti-apoptotic Bcl-2 protein and a cell cycle arrest in G1 phase, whereas apoptosis is associated with low levels of Bcl-2 and a cell cycle arrest in G2 phase. Here we show that Bcl-2, which can inhibit apoptosis and proliferation, turns the apoptotic phenotype into a senescent-like phenotype in G2 phase. This result suggests that Bcl-2-dependent inhibition of apoptosis could be crucial for the commitment to replicative senescence, whereas its ability to inhibit G1 progression would not be required.
Elsevier